Please login to the form below

Aptuit

Aptuit is a pharmaceutical services company that delivers early to mid-phase drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry.

This is a FREE listing




Below are full profiles from other companies in this area

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making connections with clients and research participants alike. Flexibility, creativity and the desire to do what is right for your business drive what we do.

View profile

Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

View profile

Company Details

Aptuit

Telephone:+39 045 8218111

Address:
Via Alessandro Fleming 4
37135 Verona (VR) Italy

Latest content from PMHub

Behavioural Science in Healthcare
Personal health and wellbeing has never been more a part of the public conscious than it is now.
Page & Page
Why aren't doctors using digital therapeutics?
The digital therapeutics market is set to reach almost $1 billion by 2026 as wearables and apps continue to play an important role in enhancing healthcare. However, adoption of these tools by healthcare professionals is comparatively low. Senior User Experience Consultant Stewart Anderson explains why.
Blue Latitude Health
Happy 2nd birthday to Porterhouse Insights
Porterhouse Medical Group is celebrating another successful year of providing powerful insight-led solutions to its global clients. Porterhouse Medical Group
New recommendations to stimulate braver and bolder communications
Cannes or Canned? report draws on expertise from within and beyond the pharmaceutical industry to make recommendations for pharma communicators 90TEN